Bionano genomics news.
Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...
About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business ...The human body’s development can be a tricky business. Different DNA sequences and genomes all play huge roles in things like immune responses and neurological capacities. The genomes people possess are deciding factors in everything all th...An Accounting Trick Not to Neglect. Shareholders of Bionano Genomics have been diluted in the past year, with total shares outstanding growing by 6.4%.. This is the base news for valuation ...About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing ...
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0 million aggregate principal amount of senior secured convertible notes ...
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from researchers...
Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ...Bionano Genomics-stock News for Bionano Genomics Bionano Genomics MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301Following the downgrade, the current consensus from Bionano Genomics' five analysts is for revenues of US$40m in 2023 which - if met - would reflect a huge 53% increase on its sales over the past ...Bionano Genomics. SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO ...SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Chinese OEM partner, Ecobono, a distribution …
SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2023. Q2 2023 Highlights
2 Jul 2021 ... We explored the potential of a new technique, called Optical Genome Mapping (OGM) with the Saphyr system from Bionano Genomics for FSHD ...
News Release Details « Back. Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress. Aug 04, 2022 | PDF Version - 73% year-over-year revenue growth in Q2 2022 - Achieved all 1H 2022 ELEVATE! milestones - Strong balance sheet with $187.3 million in cash, cash equivalents, and …About Bionano Genomics. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.Price Target and Analysts Recommendations: Three buys and one hold from analysts covering the stock. Oppenheimer's analyst Kevin DeGeeter maintained a Buy rating on February 2021, setting a price target of $15 which is approximately 75% above today´s share price of $8.59 (03/18/2021). DeGeeter expects BioNano Genomics Inc to post earnings …21 Jun 2018 ... The company makes a genome mapping system called Irys®, which offers highresolution, single-molecule analysis of long strands of DNA. BioNano ...Bionano Genomics SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company …Get the latest Bionano Genomics, Inc. (BNGO) stock news and headlines to help you in your trading and investing decisions.Aug 14, 2023 · SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory role.
According to data from Benzinga Pro, BioNano Genomics is trading lower by 1.6% to $1.23. BNGO has a 52-week high of $4.35 and a 52-week low of $1.16. Photo via Shutterstock.We would like to show you a description here but the site won’t allow us.UPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates. Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022. Installed base of Saphyr® systems reached 259 as of March 31, 2023, which represents growth of the …Dec 31, 2022 · SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported certain unaudited preliminary financial and commercial highlights for the fourth quarter and fiscal year ended December 31, 2022. The Company’s full results for the fourth quarter and the fiscal year ended December 31, 2022 are not yet available. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...
BNGO Stock 12 Months Forecast. $6.33. (298.11% Upside) Based on 3 Wall Street analysts offering 12 month price targets for BioNano Genomics in the last 3 months. The average price target is $6.33 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 298.11% change from the last price of $1.59.
A big change in the C-suite was behind the steep fall in Bionano Genomics ' ( BNGO -12.27%) share price on Monday. Following the biotech's announcement that its CFO is stepping down, investors ...Mar 7, 2023 · Bionano Genomics. Market Cap. $61M. Today's Change. (4.64%) $0.07. Current Price. $1.58. Price as of November 29, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ... SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Chinese OEM partner, Ecobono, a distribution …Mar 7, 2023 · Bionano Genomics. Market Cap. $61M. Today's Change. (4.64%) $0.07. Current Price. $1.58. Price as of November 29, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ... 9 Mar 2023 ... News Release Details. « Back. Bionano Genomics Reports Fourth Quarter and Full-Year 2022 Results and Provides Revenue Outlook for 2023. Mar 09 ...About Bionano Genomics, Inc. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.7 Agu 2023 ... Bionano Genomics (NASDAQ: BNGO) stock will jump 1000% at the open this morning. BNGO stock rising 10x is not, sadly, to make up for the ...
We believe this technology-centric view is holding us back from the answers to critical questions around the origin, diagnosis, severity and treatment of cancer and genetic disease. We believe the way to move forward is an inclusive one that reveals what other tools miss and unifies data across technologies into one view to maximize the ...
View the latest Bionano Genomics Inc. (BNGO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern ...According to data from Benzinga Pro, BioNano Genomics is trading lower by 1.6% to $1.23. BNGO has a 52-week high of $4.35 and a 52-week low of $1.16. Photo via Shutterstock.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.00, with a high estimate of 24.00 and a low estimate of 6.00. The median ...Aug 9, 2023 · Nov 3, 2022 at 4:30 PM EDT. Sep 12, 2022 at 7:00 AM EDT. 2022 Maxim Virtual Growth Conference. Mar 15, 2022 at 8:40 AM EDT. Please click HERE to join. Mar 9, 2022 at 2:10 PM EST. 42nd Annual Cowen Healthcare Conference. Please click HERE to join. Mar 1, 2022 at 4:30 PM EST. SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2023. Q1 2023 HighlightsNov 1, 2023 · Company Contact: Erik Holmlin, CEO Bionano Genomics, Inc. +1 (858) 888-7610 [email protected] Investor Relations: David Holmes Gilmartin Group +1 (858) 888-7625 [email protected] Nov 3, 2022 · SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today reported financial results for the third quarter ended September 30, 2022. Earnings for Bionano Genomics are expected to decrease in the coming year, from ($2.18) to ($2.85) per share. Bionano Genomics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates. Read More.May 10, 2023 · For full-year 2023, Bionano reiterated its revenue guidance of $35.0 million to $38.0 million. The company’s Q2 revenues are expected to be in the range of $7.8 million to $8.3 million. In early morning trading on the Nasdaq, Bionano's shares were up about 7 percent at $.79. Mar 13, 2023 · Bionano Genomics, Inc. +1 (858) 888-7610. [email protected]. Investor Relations: Amy Conrad. Juniper Point. +1 (858) 366-3243. [email protected]. Bionano CEO and president Dr. Erik Holmlin ... SAN DIEGO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a study detailing the challenges associated with the detection and interpretation of causal variants in Mendelian disease, using a cohort of 4,577 families.The study authors conducted a comprehensive analysis of samples from …Get the latest BioNano Genomics Inc (BNGO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Nov 30, 2023 · SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the publication by scientists at Revvity Omics (formerly Perkin Elmer Genomics), Leiden University Medical Centre, Bombay Hospital, and UT Dallas, of the largest peer-reviewed study to date on the use of optical genome mapping (OGM) to diagnose facioscapulohumeral muscular dystrophy (FSHD). SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory …An Accounting Trick Not to Neglect. Shareholders of Bionano Genomics have been diluted in the past year, with total shares outstanding growing by 6.4%.. This is the base news for valuation ...SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today.The final voting results will be available in a current report on Form 8-K, which will be filed with the SEC within 4 days of the meeting. “We appreciate …Instagram:https://instagram. best mortgage lenders in kentuckycrowdstreet newsappl callssocial security in 2024 InvestorPlace - Stock Market News, Stock Advice & Trading Tips. After surging to an all-time high early in 2021, Bionano Genomics (NASDAQ: BNGO) stock is back down among the penny stocks.The first ...Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.75. Operator: Good day, and welcome to the Bionano's Third Quarter 2023 Earnings Conference Call. is blackrock a good investmentbest real estate stocks to buy Aug 30, 2023 · SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as an alternative to karyotyping (KT) and chromosomal microarray (CMA) for the evaluation of CRISPR-Cas9 edited human induced pluripotent stem cell (iPSC) lines in order to uncover possible pathogenic ... BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics' PT to $15 From $1.50, Citing Balance Sheet Expansion, Potential of $100 Genome; Outperform Rating Kept 2021: MT BIONANO GENOMICS : Roth Capital Downgrades Bionano Genomics to Neutral From Buy; Price Target is $0.75 2020 voc energy trust stock Sep 30, 2021 · – Acquisition of BioDiscove ry transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics – Total revenue of $4.7 million , a 112% year-over-year total revenue increase, driven by Nov 8, 2023 · SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2023. Business Updates Since the End ...